Out of petty cash (market cap $760 B) and still have a major APPROVED drug for LESS than their own research could do it.
. Lets not even talk about what GPCR is worth.
Europe .. look out.
Hope you cover before they offer.
The short squeeze is overdue.
Will Roche outbid them?
No one buying out ARNA the partner got the good part the rest is scraps
PFE could pay 20B for Eisai-Arena.
Really..... after all they swallowed up Warner-Lambert with only a tiny little burp.
This is one thing people tend to overlook that the possibility does exist that Arena can get bought out any time.
Could happen as fast as you can spit.
Just to keep things honest... PFE's market cap is $208B, not $760B.
However, they do have $32B in cash and short term investments.
Sentiment: Strong Buy
What the heck are you smoking???
If is that good give it to Pfizer execs.
Hoffman just unloaded a ton of shares. THERE ARE NO BUYOUT NEGOTIATIONS got it.
And monkeys could fly out of my #$%$
This is not going to play out like we all hoped. ARNA is being surpressed. They will most likely be bought but not by Pfizer.